Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.
"(hard to see what it adds really to funds already available.)"
Spikeyj, nothing to you or me but it helps Woody's bonus an awful lot. Still he can boast about his long term reputation for a while longer and diss any short term losses for a few years anyway.
I suspect there will be a few having second thoughts after recent struggles in one of his funds but that is what happens when people give you wadges of dosh to invest for them. You invest it no matter what rather than wait… Read More
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.